Home Mission Services Special Service Competencies

 

WELCOME TO

 

KellSa s.a.s.

 

 

Kjell S. Sakariassen, PhD, FAHA

Head of KellSa s.a.s.

Str. Campo e Zampe 12

I-13900 Biella, BI, Italy

 

 

Professional Experience

 

1984 1985: Post-doctoral ( I )

Thrombosis and Atherosclerosis Research Group

F. Hoffmann-La Roche Ltd., Basle, Switzerland

Head: Professor Hans R. Baumgartner

 

1985 1987: Post-doctoral ( II )

Department of Pathology

University of Washington, Seattle, WA

Head: Professor Russel Ross

 

1987 1990: Research Scientist

Preclinical Cardiovascular Research

F. Hoffmann-La Roche Ltd., Basle Switzerland

Head: Professor Hans R. Baumgartner

 

1990 1992: Group Leader

Biotechnology Centre of Oslo

University of Oslo, Oslo, Norway

Head: Professor Hans Prydz

 

1992 1998: Director of Discovery Research

- Cardiovascular Discovery

- Pharmacology

- Haemostasis Discovery

- Haemostasis and Cardiovascular Diagnostics

Nycomed Bioreg, Nycomed Pharma, Nycomed Imaging and

Nycomed Amersham Imaging, Oslo, Norway

 

1993 1998: Professor of Physiology

Division of Physiology, Department of Biology

University of Oslo, Oslo, Norway

 

 

1998 2001: Deputy Director and Director of Pharmacology

- Endocrine Pharmacology, Uppsala

- Metabolic Pharmacology, Uppsala

- Animal Sciences, Uppsala

- Pharmacology Technologies, Stockholm

- Transgene and KO Pharmacology, Karolinska Institute, Stockholm

Pharmacia & Upjohn, Pharmacia Corporation and Biovitrum,

Uppsala and Stockholm, Sweden

 

2001 2004: Worldwide Head of Pharmacology and Early Safety Evaluation

-         Early Safety Evaluation, Ivrea

-         Transgene and KO Pharmacology, Ivrea, Geneva and Boston

-         Neuro Pharmacology, Ivrea and Geneva

-         Immuno Pharmacology, Ivrea and Geneva

-         Metabolic Pharmacology, Ivrea, Geneva and Boston

-         Functional Pharmacogenomics, Ivrea

-         Reproductive Pharmacology, Ivrea and Boston

-         Cancer Pharmacology, Ivrea and Boston

Serono Int. S.A., Ivrea, Italy, Geneva, Switzerland, and Boston, MA

 

2004 Present: Founder, Owner and Head

Consultation and training of local research teams in novel and unique

technologies

-         Haemostasis

-         Thrombosis

-         Arteriosclerosis

-         Obesity

-         Diabetes

-         Autoimmune / Inflammatory diseases

KellSa s.a.s., Biella, Italy